Apeameokhai Aitsebaomo
Optometrist · Houston, TXNPI 1710980438
Payments from drug & device makers
Across 97 payments — averaging $66.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Coopervision Inc.$2K
- Johnson & Johnson Vision Care, Inc.$765
- Bausch & Lomb Americas Inc.$730
- AbbVie$275
- Bausch & Lomb, A Division Of Bausch Health US, LLC$269
- plus $1K from 11 others
What the payments were for
- Consulting fees$1,30020%
- Speaking & faculty fees$65010%
- Travel & lodging$1,12218%
- Food & beverage$3,33752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 25 | $1,655 |
| Coopervision Inc. | 24 | $1,533 |
| Johnson & Johnson Vision Care, Inc. | 19 | $765 |
| Bausch & Lomb Americas Inc. | 7 | $730 |
| AbbVie(2 entities) | 4 | $275 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $269 |
| Biotissue Holdings Inc. | 2 | $201 |
| Lumenis BE Inc | 1 | $171 |
| Carl Zeiss Meditec USA, Inc. | 2 | $140 |
| Novartis | 2 | $130 |
| Apellis Pharmaceuticals, Inc. | 1 | $122 |
| Astellas Pharma US Inc | 1 | $122 |
| Dompe US, Inc. | 1 | $119 |
| Optovue, Inc. | 1 | $87 |
| Carl Zeiss Meditec, Inc. | 1 | $49 |
| Sight Sciences, Inc. | 1 | $32 |
| Visioneering Technologies, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIR OPTIX$868
- DAILIES TOTAL1 Multifocal$868
- Dailies Aqua Comfort Plus$868
- Non-Product Brand Specific$614
- LOTEMAX SM$463
- VYZULTA$368
- VUITY$209
- optilight$171
- CIRRUS HD-OCT$135
- MIEBO$125
- LOTEMAX$123
- Syfovre$122
- Oxervate$119
- XIIDRA$117
- REVIVE$107
- MyDay Contact Lens$100
How this compares
$6,409 in reported general payments places this provider in the 90th percentile of 4,315 optometrist providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 17 | $4,836 |
| CombiganBrimonidine Tartrate/Timolol | 11 | $2,343 |
| Latanoprost | 31 | $722 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan | $275 | $7,17928 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,315 optometrist providers in Texas.
Other optometrist in Houston
- Tiffany HuynhHouston$3.2M
- Bridgitte LeeHouston$3M
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
- Kathryn RichdaleHouston$288K
- Nancy StephensHouston$241K
- Jelita Green-DathorneHouston$232K
- Eric RitcheyHouston$151K
- Maria WalkerHouston$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.